Armata Pharmaceuticals SG&A Expense (TTM) Insights

Armata Pharmaceuticals Inc (ARMP)

2.36 +0.07 (+3.06%) USD | NYAM | Sep 27, 16:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1995. Upgrade now.

Date	Value
June 30, 2024	13.38M
March 31, 2024	12.29M
December 31, 2023	11.65M
September 30, 2023	10.28M
June 30, 2023	8.259M
March 31, 2023	7.992M
December 31, 2022	7.437M
September 30, 2022	7.85M
June 30, 2022	8.057M
March 31, 2022	8.113M
December 31, 2021	8.281M
September 30, 2021	8.035M
June 30, 2021	8.112M
March 31, 2021	7.946M
December 31, 2020	7.966M
September 30, 2020	8.034M
June 30, 2020	9.947M
March 31, 2020	10.06M
December 31, 2019	9.265M
September 30, 2019	11.21M
June 30, 2019	7.969M
March 31, 2019	7.247M
December 31, 2018	7.458M
September 30, 2018	4.76M
June 30, 2018	5.859M

Date	Value
March 31, 2018	7.283M
December 31, 2017	7.59M
September 30, 2017	7.832M
June 30, 2017	8.00M
March 31, 2017	7.667M
December 31, 2016	8.413M
September 30, 2016	8.729M
June 30, 2016	8.791M
March 31, 2016	7.957M
December 31, 2015	6.71M
September 30, 2015	6.418M
June 30, 2015	6.276M
March 31, 2015	6.62M
December 31, 2014	6.85M
September 30, 2014	6.513M
June 30, 2014	6.027M
March 31, 2014	6.909M
December 31, 2013	5.996M
September 30, 2013	6.124M
June 30, 2013	5.945M
March 31, 2013	4.463M
September 30, 2009	4.706M
June 30, 2009	4.578M
March 31, 2009	5.294M
December 31, 2008	5.822M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

7.437M

Minimum

Dec 2022

13.38M

Maximum

Jun 2024

9.208M

Average

8.186M

Median

SG&A Expense (TTM) Benchmarks